These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8396943)
1. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells. Gallwitz B; Witt M; Fölsch UR; Creutzfeldt W; Schmidt WE J Mol Endocrinol; 1993 Jun; 10(3):259-68. PubMed ID: 8396943 [TBL] [Abstract][Full Text] [Related]
2. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871 [TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells. Gallwitz B; Schmidt WE; Conlon JM; Creutzfeldt W J Mol Endocrinol; 1990 Aug; 5(1):33-9. PubMed ID: 2168708 [TBL] [Abstract][Full Text] [Related]
4. GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1. Gallwitz B; Witt M; Morys-Wortmann C; Fölsch UR; Schmidt WE Regul Pept; 1996 May; 63(1):17-22. PubMed ID: 8795084 [TBL] [Abstract][Full Text] [Related]
5. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor. Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060 [TBL] [Abstract][Full Text] [Related]
6. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143 [TBL] [Abstract][Full Text] [Related]
7. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells. Göke R; Conlon JM J Endocrinol; 1988 Mar; 116(3):357-62. PubMed ID: 2832504 [TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. Volz A; Göke R; Lankat-Buttgereit B; Fehmann HC; Bode HP; Göke B FEBS Lett; 1995 Oct; 373(1):23-9. PubMed ID: 7589426 [TBL] [Abstract][Full Text] [Related]
9. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin. Gault VA; O'Harte FP; Harriott P; Mooney MH; Green BD; Flatt PR Diabetologia; 2003 Feb; 46(2):222-30. PubMed ID: 12627321 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of glucagon-like peptide-1(7-36)amide: insulinotropic activities in perfused rat pancreases, and receptor binding and cyclic AMP production in RINm5F cells. Watanabe Y; Kawai K; Ohashi S; Yokota C; Suzuki S; Yamashita K J Endocrinol; 1994 Jan; 140(1):45-52. PubMed ID: 8138751 [TBL] [Abstract][Full Text] [Related]
11. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. Oben J; Morgan L; Fletcher J; Marks V J Endocrinol; 1991 Aug; 130(2):267-72. PubMed ID: 1919397 [TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes. Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327 [TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Mentlein R; Gallwitz B; Schmidt WE Eur J Biochem; 1993 Jun; 214(3):829-35. PubMed ID: 8100523 [TBL] [Abstract][Full Text] [Related]
14. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823 [TBL] [Abstract][Full Text] [Related]
15. Homologous desensitization of the insulinotropic glucagon-like peptide-I (7-37) receptor on insulinoma (HIT-T15) cells. Fehmann HC; Habener JF Endocrinology; 1991 Jun; 128(6):2880-8. PubMed ID: 1645253 [TBL] [Abstract][Full Text] [Related]
16. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas. Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941 [TBL] [Abstract][Full Text] [Related]
17. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027 [TBL] [Abstract][Full Text] [Related]
18. Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway. Mazzocchi G; Rebuffat P; Meneghelli V; Malendowicz LK; Tortorella C; Gottardo G; Nussdorfer GG Peptides; 1999; 20(5):589-94. PubMed ID: 10465510 [TBL] [Abstract][Full Text] [Related]
19. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line. Fehmann HC; Habener JF FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112 [TBL] [Abstract][Full Text] [Related]
20. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. Montrose-Rafizadeh C; Yang H; Wang Y; Roth J; Montrose MH; Adams LG J Cell Physiol; 1997 Sep; 172(3):275-83. PubMed ID: 9284947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]